Results from four rounds of ovarian cancer screening in a randomized trial

Obstetrics and Gynecology

Volumn 113, Issue 4, 2009, Pages 775-782

  Partridge, Edward ^a,b   Kreimer, Aimee R ^b   Greenlee, Robert T ^b   Williams, Craig ^b   Xu, Jian Lun ^b   Church, Timothy R ^b   Kessel, Bruce ^b   Johnson, Christine C ^b   Weissfeld, Joel L ^b   Isaacs, Claudine ^b   Andriole, Gerald L ^b   Ogden, Sheryl ^b   Ragard, Lawrence R ^b   Buys, Saundra S ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARIECTOMY; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY; TUMOR BIOPSY; BLOOD; ECHOGRAPHY; EVIDENCE BASED MEDICINE; MASS SCREENING; MIDDLE AGED; MORTALITY; OVARY TUMOR; PATHOLOGY; PATIENT COMPLIANCE; PREDICTION AND FORECASTING; STANDARD; UTILIZATION REVIEW;

AGED; CA-125 ANTIGEN; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; ULTRASONOGRAPHY;

EID: 65649129680     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31819cda77     Document Type: Article

References (12)

1. American Cancer Society, Inc. Cancer Facts and Figures 2007. Atlanta (GA): American Cancer Society; 2007.
2. Ries LA, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al, editors. SEER Cancer Statistics Review, 1975-2003. Bethesda (MD): National Cancer Institute; 2005. Based on November 2005 Surveillance, Epidemiology, and End Results data submission, posted to the SEER Web site, 2006. Available at : http://seer.cancer.gov/csr/1975-2003/. Retrieved January 30, 2009.
3. DePriest PD, Gallion HH, Pavlik EJ, Kryscio RJ, van Nagell JR Jr. Transvaginal sonography as a screening method for the detection of early ovarian cancer. Gynecol Oncol 1997;65: 408-14.
4. van Nagell JR Jr, DePriest PD, Reedy MB, Gallion HH, Ueland FR, Pavlik EJ, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 2000;77:350-6.
5. Sato S, Yokoyama Y, Sakamoto T, Futagami M, Saito Y. Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography. Cancer 2000;89:582-8.
6. Einhorn N, Sjovall K, Knapp RC, Hall P, Scully RE, Bast RC Jr, et al. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol 1992;80: 14-8.
7. Jacobs IJ, Skates S, Davies AP, Woolas RP, Jeyerajah A, Weidemann P, et al. Risk of diagnosis of ovarian cancer after raised serum CA-125 concentration: a prospective cohort study. BMJ 1996;313:1355-8.
8. Skates SJ, Menon U, MacDonald N, Rosenthal AN, Oram DH, Knapp RC, et al. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol 2003;21:206s-10s.
9. Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial [published erratum appears in Am J Obstet Gynecol 2005;193:2183-4]. Am J Obstet Gynecol 2005;193:1630-9.
10. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Control Clin Trials 2000;21:273S-309S.
11. Menon U, Skates SJ, Lewis S, Rosenthal A, Rufford B, Sibley K, et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol 2005;23 (31):7919-26.
12. Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, et al. A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer 2008;18:414-20.